“Formulation and Evaluation of Orodispersible Tablet Containing Combination of Phosphodiesterase-5 Inhibitor and Herbal Aphrodisiac”, Int J Ayu Pharm Res, vol. 11, no. 2, pp. 13–30, Mar. 2023, doi: 10.47070/ijapr.v11i2.2700.